FDA Approval for Zanidatamab-Hrii: A New Era in Biliary Tract Cancer Treatment

The FDA granted Jazz Pharmaceuticals’ zanidatamab-hrii, an innovative therapy for select biliary tract cancers, the coveted stamp of…